These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16219481)

  • 61. Estimating the cost of radiotherapy for 5-year local control and overall survival benefit.
    Batumalai V; Wong K; Shafiq J; Hanna TP; Gabriel G; Heberle J; Koprivic I; Kaadan N; King O; Tran T; Cassapi L; Forstner D; Delaney GP; Barton M
    Radiother Oncol; 2019 Jul; 136():154-160. PubMed ID: 31015119
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cost management. Contracted radiation therapy services.
    Lazear M
    Adm Radiol; 1991 Oct; 10(10):57-60. PubMed ID: 10114788
    [No Abstract]   [Full Text] [Related]  

  • 63. The costs of hyperfractionation: an economic analysis incorporating consideration of waiting time for treatment.
    Munro AJ
    Clin Oncol (R Coll Radiol); 1995; 7(3):162-7. PubMed ID: 7547518
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Health Economic and Health Service Issues of Palliative Radiotherapy.
    Barton M; Batumalai V; Spencer K
    Clin Oncol (R Coll Radiol); 2020 Nov; 32(11):775-780. PubMed ID: 32646615
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Access to innovative radiotherapy: how to make it happen from an economic perspective?
    Lievens Y
    Acta Oncol; 2017 Nov; 56(11):1353-1358. PubMed ID: 28830260
    [No Abstract]   [Full Text] [Related]  

  • 66. Planning in radiotherapy: practical aspects.
    Rhys-Lewis RD
    Proc R Soc Med; 1975 Dec; 68(12):751-3. PubMed ID: 56753
    [No Abstract]   [Full Text] [Related]  

  • 67. [Economic aspects of the fight against cancer].
    Shubin BM; Rutgaĭzer VM; Khadzhiev MA; Aleksandrorva LA
    Sov Med; 1984; (5):64-8. PubMed ID: 6431616
    [No Abstract]   [Full Text] [Related]  

  • 68. Estimating surgery, radiotherapy and systemic anti-cancer therapy treatment costs for cancer patients by stage at diagnosis.
    Wills L; Nagarwalla D; Pearson C; McPhail S; Hinchliffe R; Sharpless B; Fardus-Reid F; Ambler L; Harrison S; Shelton J
    Eur J Health Econ; 2024 Jul; 25(5):763-774. PubMed ID: 37656260
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cost evaluation to optimise radiation therapy implementation in different income settings: A time-driven activity-based analysis.
    Van Dyk J; Zubizarreta E; Lievens Y
    Radiother Oncol; 2017 Nov; 125(2):178-185. PubMed ID: 28947098
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001--summary and conclusions.
    Ringborg U; Bergqvist D; Brorsson B; Cavallin-Ståhl E; Ceberg J; Einhorn N; Frödin JE; Järhult J; Lamnevik G; Lindholm C; Littbrand B; Norlund A; Nylén U; Rosén M; Svensson H; Möller TR
    Acta Oncol; 2003; 42(5-6):357-65. PubMed ID: 14596499
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Radiotherapy for Cancer. Summary.
    Acta Oncol; 1996; 35 Suppl 6():9-23. PubMed ID: 9181762
    [No Abstract]   [Full Text] [Related]  

  • 72. Implementing radiotherapy in Africa: Focus on the needs in Rwanda.
    Kamanzi JB; Adeduntan R; Antoni D; Musafiri S; Noël G
    Cancer Radiother; 2016 May; 20(3):231-5. PubMed ID: 27133894
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Could the evaluation of the cost of complications be a worthwhile means to improve radiotherapy?].
    Daly-Schveitzer N
    Cancer Radiother; 1997; 1(6):836-47. PubMed ID: 9614903
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The challenge of sustainability in healthcare systems: cost of radiotherapy in the last month of life in an Italian cancer center.
    Rossi R; Danesi V; Massa I; Balzi W; Romeo A; Foca F; Nanni O; Maltoni M; Altini M
    Support Care Cancer; 2021 May; 29(5):2735-2742. PubMed ID: 32989523
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Radiation therapy: a long term cost benefit analysis in a North American region.
    Glazebrook GA
    Clin Oncol (R Coll Radiol); 1992 Sep; 4(5):302-5. PubMed ID: 1390347
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Myth: we can tailor palliative care to match life expectancy. Reality: no we can't.
    Hartsell WF
    Cancer; 2010 Jul; 116(13):3078-9. PubMed ID: 20564639
    [No Abstract]   [Full Text] [Related]  

  • 77. Palliative radiotherapy: history, recent advances, and future directions.
    Lutz ST
    Ann Palliat Med; 2019 Jul; 8(3):240-245. PubMed ID: 30943739
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Socioeconomic aspects of ambulatory radiotherapy].
    Vazhenin AV; Abdullina NA; Klipfel' AE; Rumiantsev AP
    Vopr Onkol; 1990; 36(4):479-82. PubMed ID: 2346000
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [A new SBU report. Palliative radiotherapy of cancer should be increased].
    Lakartidningen; 1996 Sep; 93(37):3165-8. PubMed ID: 8847941
    [No Abstract]   [Full Text] [Related]  

  • 80. Light ion facility projects in Europe: methodological aspects for the calculation of the treatment cost per protocol.
    Pommier P; Zucca L; Näslund I; Auberger T; Combs SE; François G; Heeren G; Rochat J; Perrier L
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S183-5. PubMed ID: 15971339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.